Affordable Access

Publisher Website

Living donor liver transplantation in patients with hepatitis C

Authors
Journal
Liver Transplantation
1527-6465
Publisher
Wiley Blackwell (John Wiley & Sons)
Publication Date
Volume
9
Issue
11
Identifiers
DOI: 10.1053/jlts.2003.50256
Disciplines
  • Medicine

Abstract

Key Points 1. Hepatitis C virus (HCV) is the most common indication for living donor liver transplantation (LDLT). 2. Preliminary evidence suggests that HCV may occur earlier and may be more severe in LDLT recipients. However, current data is inconclusive relative to the impact of recurrent HCV on patient and graft survival in LDLT recipients. 3. Potential mechanisms for differences in severity of HCV in LDLT recipients are discussed. 4. LDLT remains a viable treatment option for selected patients with HCV.

There are no comments yet on this publication. Be the first to share your thoughts.